CA2179294A1 - Low molecular weight hyaluronic acid with peptide or protein - Google Patents

Low molecular weight hyaluronic acid with peptide or protein

Info

Publication number
CA2179294A1
CA2179294A1 CA002179294A CA2179294A CA2179294A1 CA 2179294 A1 CA2179294 A1 CA 2179294A1 CA 002179294 A CA002179294 A CA 002179294A CA 2179294 A CA2179294 A CA 2179294A CA 2179294 A1 CA2179294 A1 CA 2179294A1
Authority
CA
Canada
Prior art keywords
molecular weight
hyaluronic acid
peptide
protein
weight hyaluronic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002179294A
Other languages
French (fr)
Other versions
CA2179294C (en
Inventor
Gustaf Jederstrom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9400036A external-priority patent/SE9400036D0/en
Application filed by Individual filed Critical Individual
Publication of CA2179294A1 publication Critical patent/CA2179294A1/en
Application granted granted Critical
Publication of CA2179294C publication Critical patent/CA2179294C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/27Growth hormone [GH], i.e. somatotropin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28Polysaccharides or their derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to freeze dried soft, flexible and continous matrix of low-molecular weight hyaluronic acid or salt thereof, in which the molecular weight of the hyaluronic acid is preferably between 50 000 and 200 000 Da, containing at least one peptide or protein.
It also relates to a pharmaceutical composition in the form of a layer which is characterised by this freeze-dried low-molecular weight hyaluronic acid containing at least one peptide or protein. The drug is preferably chosen from at least one of GH, IGF-I, IGP-II and/or EGF and could be mixtured with an antibiotic agent. The process for the manufacture of this matrix and the use of the pharmaceutical composition for the manufacturing of a drug for wound healing is claimed. The invention discloses a method for accurately obtaining a predetermined dosage of a topically administerable drug which is characterised by freeze-drying a water solution of low-molecular weight hyaluronic acid and the peptide or protein to form a layer.
CA002179294A 1994-01-10 1995-01-10 Low molecular weight hyaluronic acid with peptide or protein Expired - Fee Related CA2179294C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9400036A SE9400036D0 (en) 1994-01-10 1994-01-10 Low modecular weight hyaluronic acid
SE9400036-1 1994-01-10
PCT/SE1995/000011 WO1995018635A1 (en) 1994-01-10 1995-01-10 Low molecular weight hyaluronic acid with peptide or protein

Publications (2)

Publication Number Publication Date
CA2179294A1 true CA2179294A1 (en) 1995-07-13
CA2179294C CA2179294C (en) 2006-12-12

Family

ID=37561031

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002179294A Expired - Fee Related CA2179294C (en) 1994-01-10 1995-01-10 Low molecular weight hyaluronic acid with peptide or protein

Country Status (1)

Country Link
CA (1) CA2179294C (en)

Also Published As

Publication number Publication date
CA2179294C (en) 2006-12-12

Similar Documents

Publication Publication Date Title
AU1469295A (en) Low molecular weight hyaluronic acid with peptide or protein
US6124273A (en) Chitin hydrogels, methods of their production and use
EP1325754B1 (en) Wound dressing materials comprising collagen and oxidized cellulose
ES2215645T3 (en) QUICK DISPERSION DOSAGE FORMS CONTAINING FISH GELATINE.
US20030212005A1 (en) Composition and method for growing, protecting, and healing tissues and cells
AU632539B2 (en) Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings
CA2134348A1 (en) Polysaccharide derivatives and drug carriers
KR890003400A (en) Bioactive Peptide Powder Composition (Formulation) for Nasal Administration
PT94842A (en) METHOD FOR PREPARING A PHARMACEUTICAL COMPOSITION IN THE FORM OF MICROPARTICULES OF A LACTIC AND GLYCOLIC ACID COPOLYMER AND INCORPORATING AS AN ACTIVE SUBSTANCE A PAMOATE, TANATE, ESTEARATE OR PALMITATE OF A NATURAL OR SYNTHETIC PEPTIDE
CA2059865A1 (en) Pharmaceutical Compositions Containing Orally Absorbable Glycosaminoglycans
CA2032059A1 (en) Wound treatment employing biologically active peptides
JPS6147413A (en) Active compound depot agent
US6147053A (en) Combination containing growth factors and polyelectrolytes
CA2251281A1 (en) Drug composition with controlled drug release rate
EP0966299B1 (en) Novel oral formulations of calcitonin
AU5283890A (en) Fibroblast growth factor (fgf)-based stabilized compositions
EP0416678A1 (en) Topical compositions containing Defibrotide
CA2179294A1 (en) Low molecular weight hyaluronic acid with peptide or protein
AU762262B2 (en) Bone cement with antimicrobial peptides
AU2001289641A1 (en) Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses
US5314881A (en) Use of phosphomycin and the pharmaceutically acceptable salts thereof as a topical cicatrizer
EP0354714A3 (en) Pharmaceutical compositions containing polyaromatic compounds
EP0137743A3 (en) Topically administrable pharmaceutical compositions
FR2684878B1 (en) STABILIZED PHARMACEUTICAL COMPOSITION OF RECOMBINANT, NON-GLYCOSYLATED HUMAN IL2 IN REDUCED FORM AND PROCESS FOR PREPARING THE SAME.
DE3585936D1 (en) BIOLOGICALLY ACTIVE PEPTIDES, THEIR METHOD FOR THE PRODUCTION AND PHARMACEUTICAL COMPOSITIONS.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed